7Baggers
 Mainz Biomed to Attend the 38th Annual Meeting of the  GlobeNewswire Mon, 10 Nov 2025 13:01:00 GMT
 is mainz biomed n.v. stock a safe investment in uncertain markets  newser.com Wed, 05 Nov 2025 08:57:42 GMT

Mainz Biomed B.V.
(NASDAQ:MYNZ) 

MYNZ stock logo

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoS...

Founded: 2008
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends